Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Salvina Signorelli

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Brain Sciences|August 23, 2020
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesLaura Fusar-Poli, Vito Cavone, Silvia Tinacci, et al.
Critical Reviews in Food Science and Nutrition|August 20, 2019
Curcumin for depression: a meta-analysisLaura Fusar-Poli, Lucia Vozza, Alberto Gabbiadini, et al.
Brain Sciences|August 29, 2024
The Association between Attention-Deficit-Hyperactivity Disorder and Autistic Traits with Psychotic-like Experiences in Sample of Youths Who Were Referred to a Psychiatric Outpatient ServiceLaura Fusar-Poli, Chiara Avanzato, Giuliana Maccarone, et al.
Psychiatry Research|March 30, 2025
Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiencesSofia Francesca Aprile, Alessandro Rodolico, Antonio Di Francesco, et al.
Healthcare (Basel, Switzerland)|November 24, 2022
Smoking Addiction in Patients with Schizophrenia Spectrum Disorders and Its Perception and Intervention in Healthcare Personnel Assigned to Psycho-Rehabilitation Programs: A Qualitative ResearchPasquale Caponnetto, Marilena Maglia, Marta Mangione, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 15, 2025
Quality of life, disability and antipsychotics-related side effects in schizophrenia spectrum and bipolar disorder: the role of patient-reported outcome measuresSofia Francesca Aprile, Alessandro Rodolico, Sabrina Castellano, et al.
Expert Opinion on Pharmacotherapy|July 14, 2023
Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paperGaia Sampogna, Filippo Caraci, Claudia Carmassi, et al.
General Psychiatry|July 26, 2021
Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory studyAntonino Petralia, Emanuele Bisso, Ilaria Concas, et al.
Pharmacopsychiatry|July 13, 2026
Efficacy and tolerability of nutraceuticals and phytotherapics for antipsychotic-induced weight gain in schizophrenia spectrum disorders: Systematic review and meta-analysisAntonio Di Francesco, Antonio Munafò, Gaetano Catania, et al.
Journal of Psychiatric Research|July 7, 2023
The association between polygenic risk scores for mental disorders and social cognition: A scoping reviewLaura Fusar-Poli, Alessandro Rodolico, Miriam Martinez, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Brain Sciences|August 23, 2020
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesLaura Fusar-Poli, Vito Cavone, Silvia Tinacci, et al.
Critical Reviews in Food Science and Nutrition|August 20, 2019
Curcumin for depression: a meta-analysisLaura Fusar-Poli, Lucia Vozza, Alberto Gabbiadini, et al.
Brain Sciences|August 29, 2024
The Association between Attention-Deficit-Hyperactivity Disorder and Autistic Traits with Psychotic-like Experiences in Sample of Youths Who Were Referred to a Psychiatric Outpatient ServiceLaura Fusar-Poli, Chiara Avanzato, Giuliana Maccarone, et al.
Psychiatry Research|March 30, 2025
Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiencesSofia Francesca Aprile, Alessandro Rodolico, Antonio Di Francesco, et al.
Healthcare (Basel, Switzerland)|November 24, 2022
Smoking Addiction in Patients with Schizophrenia Spectrum Disorders and Its Perception and Intervention in Healthcare Personnel Assigned to Psycho-Rehabilitation Programs: A Qualitative ResearchPasquale Caponnetto, Marilena Maglia, Marta Mangione, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 15, 2025
Quality of life, disability and antipsychotics-related side effects in schizophrenia spectrum and bipolar disorder: the role of patient-reported outcome measuresSofia Francesca Aprile, Alessandro Rodolico, Sabrina Castellano, et al.
Expert Opinion on Pharmacotherapy|July 14, 2023
Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paperGaia Sampogna, Filippo Caraci, Claudia Carmassi, et al.
General Psychiatry|July 26, 2021
Psychopathological outcomes and defence mechanisms in clinically healed adults with a paediatric cancer history: an exploratory studyAntonino Petralia, Emanuele Bisso, Ilaria Concas, et al.
Pharmacopsychiatry|July 13, 2026
Efficacy and tolerability of nutraceuticals and phytotherapics for antipsychotic-induced weight gain in schizophrenia spectrum disorders: Systematic review and meta-analysisAntonio Di Francesco, Antonio Munafò, Gaetano Catania, et al.
Journal of Psychiatric Research|July 7, 2023
The association between polygenic risk scores for mental disorders and social cognition: A scoping reviewLaura Fusar-Poli, Alessandro Rodolico, Miriam Martinez, et al.
Pageof 9